Target intelligence / Profile preview

Rectal mucosa

Molecular classification
Other (tissue/lining, not a molecular target)
01

Overview

The **rectal mucosa** is the innermost lining layer of the rectum. It consists primarily of simple columnar epithelial cells interspersed with mucus-secreting goblet cells, supported by connective tissue known as lamina propria and a thin muscle layer called muscularis mucosae[6][7][8]. The main functions include absorbing water and electrolytes from feces to help solidify stool before defecation, secreting mucus to lubricate stool passage, and serving as a barrier against pathogens and mechanical injury[1][3][6]. The structure transitions sharply at the anorectal junction where it meets stratified squamous epithelium. While diseases such as cancer can arise from this tissue—most commonly adenocarcinoma—the "rectal mucosa" itself is an anatomical structure rather than a discrete therapeutic target like an enzyme or receptor. Therefore, it should not be classified as a druggable molecular target. **Note:** There is something incorrect about using "Rectal mucosa" as a therapeutic target name—it refers to an anatomical tissue layer rather than any single molecule/receptor/enzyme/transporter typically considered drug targets. If you are seeking information about receptors or molecules expressed within this tissue (such as certain ion channels or transporters), those should be specified individually.

Other names
Rectal liningMucosa of the rectumRectal epithelial layer
02

Mechanism of action

Drugs do not act on the "rectal mucosa" as a molecular entity but may be absorbed through it or cause local effects.

03

Biological functions

Absorption of water and electrolytes[1][3][7][9]Secretion of mucus for lubrication[6][7]Barrier function against pathogens and mechanical injury[6]
04

Disease associations

Cancer (site for rectal adenocarcinoma and other neoplasms)[4]Inflammation (site affected in proctitis, ulcerative colitis)Infection (can be involved in sexually transmitted infections)Other (hemorrhoids, trauma)
05

Safety considerations

Local irritation from drugs administered rectallyRisk of infection or trauma with invasive proceduresPotential site for neoplastic transformation in chronic inflammatory conditions[4]

Beyond the preview

Go deeper on Rectal mucosa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rectal mucosa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call